Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 化妝品應用與管理系(所) > 期刊論文 > Item 310902800/34641

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34641

標題:	Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway
作者:	Wang, Hui-Ching Luo, Chi-Wen Chen, Tzu-Yi Chen, Yi-Zi Fang, Shao-Yu Lai, Chiao-Ying Hung, Wen-Chun Wu, Chun-Chieh Chen, Li-Tzong Liu, Yi-Chang Pan, Mei-Ren
貢獻者:	Kaohsiung Medical University Kaohsiung Medical University Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung Medical University Hospital Department of Cosmetic Science and Institute of Cosmetic Science, Chia Nan University of Pharmacy & Science National Health Research Institutes - Taiwan Kaohsiung Medical University Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung Medical University Kaohsiung Medical University Hospital
關鍵字:	pancreatic ductal adenocarcinoma kinase-associated protein-2 mesenchymal transition skp2 expression drug-resistance cell-growth metastasis inactivation degradation invasion
日期:	2022
上傳時間:	2023-12-11 14:02:07 (UTC+8)
出版者:	PERGAMON-ELSEVIER SCIENCE LTD
摘要:	Aims: Pancreatic ductal adenocarcinoma (PDAC) constitutes one of the most dismal malignancies worldwide. Despite multidisciplinary involvement in interventions involving surgery, radiotherapy, and chemotherapy, most pancreatic cancer patients eventually develop distant metastasis. S-phase kinase-associated protein 2 (Skp2) plays an important role in cell-cycle regulation in pancreatic cancer. However, the role of Skp2 in individualized PDAC treatment is largely unknown.Main methods: Immunoblotting, quantitative reverse transcription polymerase chain reaction, cell viability test, chromatin immunoprecipitation assay, and xenograft in vivo assay were performed in parental and Skp2-depleted cells. The immunohistochemistry of Skp2 was analyzed on the tissue microarrays of 45 PDAC cases and mice tissues.Key findings: In this study, we observed that Skp2 is a marker for poor prognosis in PDAC patients. Upregulation of the inhibitor of Kappa B (I Kappa B)-inducing kinase-nuclear factor kappa B (NF-Kappa B) signal cascade mediated Skp2 expression thereby promoting epithelial-mesenchymal transition (EMT). Depletion of NF-Kappa B-associated signaling effectively prevented Skp2-mediated pancreatic cancer cell migration. As a functional consequence, Skp2 orchestrated with Myc to induce zinc finger E-box binding homeobox 1 (Zeb1) transcription by recruiting p300 to the Zeb1 promoter independent of Skp2 E3-ligase activity. Therefore, blockade of Skp2 could significantly reduce the expression of Zeb1 and inhibit cancer cell migration. In conclusion, Skp2 regulated Zeb1 activity to control the migration and invasion abilities of pancreatic cancer cells. Skp2 expression in PDAC may affect cell vulnerability to standard chemotherapy regimens.Significance: Therefore, in patients with PDAC, modulation of Skp2 expression could be a novel strategy for preventing cancer cell metastasis.
關聯:	LIFE SCIENCES, v.311, Part A, 121135
显示于类别:	[化妝品應用與管理系(所)] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	242	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....